$40 Million Malpractice Verdict: What Every Cardiologist Must Learn from a Missed Hypertension Call

Medicolegal Risk, Documentation Standards, and Clinical Decision-Making in Hypertensive Patients — A Physician Education Review

Figure 1 — Clinical Timeline: From Missed BP to Catastrophic Stroke

A $40 million medical malpractice verdict entered in March 2024 against Advocate Health and a primary care provider is reshaping how physicians must think about a single elevated blood pressure reading in a young patient.

The case centered on a 37-year-old man who presented to his primary care physician (PCP) in January 2015 with a two-month history of worsening cough and was found to have a blood pressure of 190/102 mmHg.

He was diagnosed with acute bronchitis and prescribed azithromycin, Tessalon Perles, Cheratussin AC, and Pulmicort — but was sent home without antihypertensive therapy.

Six weeks later, in March 2015, the patient was found in his car in respiratory distress with right-sided weakness and aphasia, with a prehospital systolic blood pressure reportedly as high as 290 mmHg.

He sustained a 5 × 4 cm basal ganglia hemorrhage, and today requires round-the-clock assistance with all activities of daily living.

The jury awarded $6 million for future medical expenses, nearly $20 million for past and future disability, and additional amounts for pain, suffering, and lost wages — covering what could be more than 30 years of total dependence.

Was This Actually a Hypertension Diagnosis?

Both the American College of Cardiology (ACC) and American Heart Association (AHA) recommend confirming elevated readings on multiple occasions before establishing a formal hypertension diagnosis.

This patient's prior blood pressure was 132/82 mmHg six months earlier at an outside clinic — a reading consistent with Stage 1 hypertension by current 2017 ACC/AHA criteria (≥130/80) but still below the 140/90 threshold used under 2015-era guidelines.

The critical question — whether a single-visit BP of 190/102 in the context of a respiratory illness warranted formal diagnosis and immediate pharmacotherapy — remains clinically debated.

JNC 8, published in 2014 and operative at the time of this encounter, recommended initiating pharmacologic treatment for diastolic BP >90 mmHg (Grade A) and systolic BP >140 mmHg (Grade E) — thresholds this patient clearly exceeded.

Plaintiff attorneys argued the patient's cough was a symptom of hypertension-driven heart failure, not bronchitis — a retrospective reframing that proved compelling to the jury.

The Pulmonary Embolism Allegation: Was It Valid?

The plaintiff's expert alleged the physician was negligent for not sending the patient to the emergency department to rule out a pulmonary embolism (PE) — despite the fact that a risk-stratification tool analysis based on available complaint data places this patient as low risk by Wells Criteria (approximately 1.3% pre-test probability).

Applying the PERC Rule, this patient would likely have been ruled out for PE without further imaging — a standard, evidence-based approach.

The expert witness opinion was widely criticized as being legally rather than clinically authored, and the allegation that any patient in their mid-30s with a two-week cough and a single elevated blood pressure reading requires a full workup including CBC, troponins, D-dimer, ABG, PFTs, echocardiogram, CXR, ECG, chest CT, and cardiopulmonary consultations does not reflect any published guideline standard.

American College of Emergency Physicians (ACEP) guidelines on asymptomatic hypertension state explicitly that routine laboratory screening is not required and that even markedly elevated asymptomatic readings do not mandate emergent intervention in the absence of target organ injury.

BP Category (2017 ACC/AHA)	Systolic (mmHg)	Diastolic (mmHg)	Recommended Action
Normal	<120	<80	Lifestyle counseling; recheck in 1 year
Elevated	120–129	<80	Lifestyle modification; recheck in 3–6 months
Stage 1 HTN	130–139	80–89	Lifestyle ± pharmacotherapy based on CV risk
Stage 2 HTN	≥140	≥90	Lifestyle + pharmacotherapy; follow up in 1 month
Hypertensive Crisis	>180	>120	Immediate evaluation; assess for target organ damage

Table 1. 2017 ACC/AHA Blood Pressure Classification and Clinical Action Thresholds. Patient's January 2015 reading of 190/102 mmHg falls in the hypertensive crisis range. Prior reading of 132/82 meets current Stage 1 criteria.

Documentation: The Real Battleground

A discrepancy between physician and medical assistant notes — the physician documented "coughing fits without dyspnea" while the MA documented "hard time breathing" — became a cornerstone of the plaintiff's narrative of carelessness.

When conflicting histories exist in a chart, best practice is to re-interview the patient with both providers present, or to explicitly document reconciliation of the discrepancy in the physician's note.

A brief addendum such as "MA note reviewed; patient specifically denied dyspnea on direct questioning" may have substantially altered the jury's perception of thoroughness.

Abnormal vital signs require documented acknowledgment — if the plan is watchful waiting or repeat measurement rather than immediate treatment, that clinical reasoning must appear in the chart.

A note reading "BP 190/102 — white coat effect possible; return in 2 weeks for repeat BP measurement" demonstrates that the finding was recognized and addressed, rather than ignored.

Return precautions — instructing patients to seek care if symptoms worsen, fail to improve, or new symptoms emerge — are a simple, high-leverage documentation tool that can shift contributory liability to the patient in cases of delayed follow-up.

The patient's February 6th phone call for URI symptoms — handled entirely as a prescription refill without any reassessment of blood pressure — represented a missed second opportunity to address an unresolved cardiovascular risk factor.

Documentation Element	Why It Matters Medicolegally	Example Language
Acknowledge abnormal vitals	Demonstrates the finding was not overlooked	"BP 190/102 noted; likely related to pain/anxiety — to be rechecked after 5 minutes"
Reconcile conflicting notes	Prevents narrative of physician carelessness	"MA note reviewed; patient denied dyspnea on direct questioning by examiner"
Document clinical reasoning for deferring treatment	Shows thoughtful decision, not negligent omission	"Initiating antihypertensives deferred pending repeat BP confirmation in 2–4 weeks"
Shared decision-making notation	Protects against failure-to-refer allegations	"Chest CT discussed; patient declined after risks/benefits explained — documented refusal"
Return precautions	Shifts burden if patient self-discharges against advice	"Patient instructed to return immediately if worsening dyspnea, chest pain, headache, or vision changes"
Follow-up plan with timeframe	Establishes standard of care was met prospectively	"Return in 2 weeks for repeat BP and reassessment"

Table 2. High-Yield Documentation Checklist for Hypertensive Encounters. Each element functions as prospective medicolegal protection.

Figure 2 — $40 Million Verdict Breakdown by Damage Category

Implications for Cardiologists and Cardiovascular Risk Management

Although this case involved a primary care encounter, cardiologists frequently receive curbside calls, serve as consultants, and co-manage patients in whom elevated blood pressure is an "incidental" finding during a visit for another indication.

Hypertensive urgency — defined as severely elevated BP (typically >180/120) without acute target organ damage — does not mandate emergent hospitalization but does require a documented management plan with close outpatient follow-up.

Hypertensive emergency, by contrast, requires immediate IV therapy and inpatient monitoring — and the distinction hinges entirely on evidence of acute target organ damage (AKI, pulmonary edema, encephalopathy, aortic dissection, NSTEMI).

In retrospect, this patient's cough — if truly related to new-onset heart failure from hypertensive cardiomyopathy — may have represented a missed sign of target organ damage, though this remains speculative given the clinical record.

The National Practitioner Data Bank (NPDB) reports that cardiovascular conditions, including hypertension-related strokes, remain among the top diagnostic categories in paid malpractice claims — making this case representative, not exceptional.

Brief Case Vignette

Clinical Scenario — Applying These Lessons

A 44-year-old male with no prior cardiac history presents to your cardiology clinic for evaluation of exertional dyspnea of 6 weeks' duration.

Triage vital signs show a blood pressure of 178/108 mmHg; the nurse attributes it to "clinic anxiety."

Your echocardiogram reveals concentric LV hypertrophy with an ejection fraction of 50% and Grade I diastolic dysfunction.

You initiate amlodipine 5 mg daily, counsel on dietary sodium restriction, and schedule repeat blood pressure assessment in 4 weeks — and you document all of this explicitly, including the vital sign, your clinical interpretation, and a return precaution for worsening symptoms.

Three months later, the patient's blood pressure is 128/80 on combination therapy, and the echo shows regression of LV wall thickness — an outcome achievable only because the abnormal vital sign was recognized, documented, and acted upon at the index visit.

This case illustrates that hypertension found incidentally in a cardiology clinic is never truly incidental — it is an actionable finding requiring the same rigor as the primary complaint.

Bottom Line for Clinicians

A single BP of 190/102 mmHg in a 37-year-old without initiating treatment or a documented follow-up plan became the foundation for a $40 million verdict nine years later.

Physicians do not need to be perfect — they need to document their reasoning, acknowledge abnormal findings, and create a clear follow-up path.

In an era of increasingly complex patients and megaverdicts, the chart is both the clinical record and the legal narrative.

References

1. Sullivan W. $40 Million Medical Malpractice Verdict for Stroke Victim. SullivanLegal.us. Published July 2024.
2. Whelton PK, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018.
3. James PA, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014.
4. American College of Emergency Physicians. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients in the Emergency Department with Asymptomatic Elevated Blood Pressure. ACEP. 2013.
5. MDCalc. Wells Criteria for Pulmonary Embolism. MDCalc.com.
6. National Practitioner Data Bank. NPDB Public Use Data File. U.S. Health Resources & Services Administration.

Physician Education Disclaimer: This article is intended for licensed healthcare professionals for educational purposes only. It does not constitute legal advice, medical advice, or a standard of care determination for any individual patient. Clinical decision-making should always be based on the full clinical context and current evidence-based guidelines. For medicolegal concerns, consult a qualified attorney with experience in healthcare law.